Analysis the patent layout strategy of foreign pharmaceutical companies in the field of chimeric antigen receptor T cell therapy:taking Kite Pharma company as an example

ZHANG Zhi-xian; SUN Shang-yu

doi:10.3969/j.issn.1003-3734.2023.15.002

Home>Articles>Analysis the patent layout strategy of foreign pharmaceutical companies in the field of chimeric antigen receptor T cell therapy:taking Kite Pharma company as an example

DOI: 10.3969/j.issn.1003-3734.2023.15.002

Analysis the patent layout strategy of foreign pharmaceutical companies in the field of chimeric antigen receptor T cell therapy:taking Kite Pharma company as an example

ZHANG Zhi-xian

SUN Shang-yu

Keywords：chimeric antigen receptor T cellpatent layoutpatent analysis

Publication Date：2023-08-15

Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)

Pages：8( 1495-1502 )

Chinese Journal of New Drugs

ISTICPKUCSCD

ISSN：1003-3734

Year, Vol.(Issue)：2023,32(15)